Literature DB >> 21741848

Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase.

Letizia Crocetti1, Maria Paola Giovannoni, Igor A Schepetkin, Mark T Quinn, Andrei I Khlebnikov, Agostino Cilibrizzi, Vittorio Dal Piaz, Alessia Graziano, Claudia Vergelli.   

Abstract

Human neutrophil elastase (HNE) plays an important role in tumour invasion and inflammation. A series of N-benzoylindazoles was synthesized and evaluated for their ability to inhibit HNE. We found that this scaffold is appropriate for HNE inhibitors and that the benzoyl fragment at position 1 is essential for activity. The most active compounds inhibited HNE activity with IC₅₀ values in the submicromolar range. Furthermore, docking studies indicated that the geometry of an inhibitor within the binding site and energetics of Michaelis complex formation were key factors influencing the inhibitor's biological activity. Thus, N-benzoylindazole derivatives and their analogs represent novel structural templates that can be utilized for further development of efficacious HNE inhibitors.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21741848      PMCID: PMC6777343          DOI: 10.1016/j.bmc.2011.06.036

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  43 in total

1.  On the activity of MR 889, a new synthetic proteinase inhibitor.

Authors:  M Luisetti; P D Piccioni; M Donnini; R Alesina; A M Donnetta; V Peona
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

Review 2.  Potential role of inhibitors of neutrophil elastase in treating diseases of the airway.

Authors:  Bilal Chughtai; Thomas G O'Riordan
Journal:  J Aerosol Med       Date:  2004

Review 3.  Novel roles of protease inhibitors in infection and inflammation.

Authors:  P S Hiemstra
Journal:  Biochem Soc Trans       Date:  2002-04       Impact factor: 5.407

4.  Azetidine-2,4-diones (4-oxo-beta-lactams) as scaffolds for designing elastase inhibitors.

Authors:  Jalmira Mulchande; Rita C Guedes; Wing-Yin Tsang; Michael I Page; Rui Moreira; Jim Iley
Journal:  J Med Chem       Date:  2008-02-22       Impact factor: 7.446

5.  Primary structure of human neutrophil elastase.

Authors:  S Sinha; W Watorek; S Karr; J Giles; W Bode; J Travis
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

6.  Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: implications for cystic fibrosis.

Authors:  M Bédard; C D McClure; N L Schiller; C Francoeur; A Cantin; M Denis
Journal:  Am J Respir Cell Mol Biol       Date:  1993-10       Impact factor: 6.914

7.  Synthesis and optimization of 2-pyridin-3-yl-benzo[d][1,3]oxazin-4-one based inhibitors of human neutrophil elastase.

Authors:  Kevin R Shreder; Julia Cajica; Lingling Du; Allister Fraser; Yi Hu; Yasushi Kohno; Emme C K Lin; Steve J Liu; Eric Okerberg; Lan Pham; Jiangyue Wu; John W Kozarich
Journal:  Bioorg Med Chem Lett       Date:  2009-06-17       Impact factor: 2.823

Review 8.  Human neutrophil elastase inhibitors in innate and adaptive immunity.

Authors:  P M Fitch; A Roghanian; S E M Howie; J-M Sallenave
Journal:  Biochem Soc Trans       Date:  2006-04       Impact factor: 5.407

Review 9.  Neutrophil elastase inhibitors as treatment for COPD.

Authors:  Hiroyuki Ohbayashi
Journal:  Expert Opin Investig Drugs       Date:  2002-07       Impact factor: 6.206

10.  [N1-substituted 1H-indazole-3-ethyl carboxylates and 1H-indazole-3-hydroxamic acids].

Authors:  G A Bistocchi; G De Meo; M Pedini; A Ricci; H Brouilhet; S Boucherie; M Rabaud; P Jacquignon
Journal:  Farmaco Sci       Date:  1981-05
View more
  10 in total

1.  Synthesis and Pharmacological Evaluation of Indole Derivatives as Deaza Analogues of Potent Human Neutrophil Elastase Inhibitors.

Authors:  Letizia Crocetti; Igor A Schepetkin; Giovanna Ciciani; Maria Paola Giovannoni; Gabriella Guerrini; Antonella Iacovone; Andrei I Khlebnikov; Liliya N Kirpotina; Mark T Quinn; Claudia Vergelli
Journal:  Drug Dev Res       Date:  2016-07-30       Impact factor: 4.360

2.  Cinnoline derivatives as human neutrophil elastase inhibitors.

Authors:  Maria Paola Giovannoni; Igor A Schepetkin; Letizia Crocetti; Giovanna Ciciani; Agostino Cilibrizzi; Gabriella Guerrini; Andrei I Khlebnikov; Mark T Quinn; Claudia Vergelli
Journal:  J Enzyme Inhib Med Chem       Date:  2015-07-21       Impact factor: 5.051

3.  Further modifications of 1H-pyrrolo[2,3-b]pyridine derivatives as inhibitors of human neutrophil elastase.

Authors:  Maria P Giovannoni; Niccolò Cantini; Letizia Crocetti; Gabriella Guerrini; Antonella Iacovone; Igor A Schepetkin; Claudia Vergelli; Andrei I Khlebnikov; Mark T Quinn
Journal:  Drug Dev Res       Date:  2019-04-19       Impact factor: 4.360

4.  Synthesis and analytical characterization of new thiazol-2-(3H)-ones as human neutrophil elastase (HNE) inhibitors.

Authors:  Letizia Crocetti; Gianluca Bartolucci; Agostino Cilibrizzi; Maria Paola Giovannoni; Gabriella Guerrini; Antonella Iacovone; Marta Menicatti; Igor A Schepetkin; Andrei I Khlebnikov; Mark T Quinn; Claudia Vergelli
Journal:  Chem Cent J       Date:  2017-12-06       Impact factor: 4.215

5.  Effects of the neutrophil elastase inhibitor EL-17 in rat adjuvant-induced arthritis.

Authors:  Lorenzo Di Cesare Mannelli; Laura Micheli; Lorenzo Cinci; Mario Maresca; Claudia Vergelli; Alessandra Pacini; Mark T Quinn; Maria Paola Giovannoni; Carla Ghelardini
Journal:  Rheumatology (Oxford)       Date:  2016-03-30       Impact factor: 7.580

6.  Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase.

Authors:  Letizia Crocetti; Igor A Schepetkin; Agostino Cilibrizzi; Alessia Graziano; Claudia Vergelli; Donatella Giomi; Andrei I Khlebnikov; Mark T Quinn; Maria Paola Giovannoni
Journal:  J Med Chem       Date:  2013-07-25       Impact factor: 7.446

7.  Isoxazol-5(2H)-one: a new scaffold for potent human neutrophil elastase (HNE) inhibitors.

Authors:  Claudia Vergelli; Igor A Schepetkin; Letizia Crocetti; Antonella Iacovone; Maria Paola Giovannoni; Gabriella Guerrini; Andrei I Khlebnikov; Samuele Ciattini; Giovanna Ciciani; Mark T Quinn
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

8.  Exploration of nitrogen heterocycle scaffolds for the development of potent human neutrophil elastase inhibitors.

Authors:  Niccolò Cantini; Andrei I Khlebnikov; Letizia Crocetti; Igor A Schepetkin; Giuseppe Floresta; Gabriella Guerrini; Claudia Vergelli; Gianluca Bartolucci; Mark T Quinn; Maria Paola Giovannoni
Journal:  Bioorg Med Chem       Date:  2020-11-06       Impact factor: 3.641

9.  Synthesis, biological evaluation, and molecular modelling studies of potent human neutrophil elastase (HNE) inhibitors.

Authors:  Maria Paola Giovannoni; Igor A Schepetkin; Mark T Quinn; Niccolò Cantini; Letizia Crocetti; Gabriella Guerrini; Antonella Iacovone; Paola Paoli; Patrizia Rossi; Gianluca Bartolucci; Marta Menicatti; Claudia Vergelli
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

10.  Novel and Modified Neutrophil Elastase Inhibitor Loaded in Topical Formulations for Psoriasis Management.

Authors:  Andreia Nunes; Joana Marto; Lídia Maria Gonçalves; Sandra Simões; Rita Félix; Andreia Ascenso; Francisca Lopes; Helena Margarida Ribeiro
Journal:  Pharmaceutics       Date:  2020-04-14       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.